References
- Helbig, I. and Abou Tayoun, A. N. (2016) ‘Understanding Genotypes and Phenotypes in Epileptic Encephalopathies’, Molecular Syndromology, 7(4), pp. 172–181.
- Light, T. P., Gomez-Soler, M., Wang, Z., Karl, K., Zapata-Mercado, E., Gehring, M. P., Lechtenberg, B. C., Pogorelov, T. V., Hristova, K. and Pasquale, E. B. (2021) ‘A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain’, Journal of Biological Chemistry, 297(1), p. 100876.
- National Center for Biotechnology Information. Clin-Var (no date) [VCV000431727.1].
- Van Hoecke, A., Schoonaert, L., Lemmens, R., Timmers, M., Staats, K. A., Laird, A. S., Peeters, E., Philips, T., Goris, A., Dubois, B., et al. (2012) ‘EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans’, Nature Medicine, 18(9), pp. 1418–1422.
- Fu, A. K. Y., Hung, K.-W., Huang, H., Gu, S., Shen, Y., Cheng, E. Y. L., Ip, F. C. F., Huang, X., Fu, W.-Y. and Ip, N. Y. (2014) ‘Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer’s disease’, Proceedings of the National Academy of Sciences, 111(27), pp. 9959–9964.
- Goldshmit, Y. and Bourne, J. (2010) ‘Upregulation of EphA4 on Astrocytes Potentially Mediates Astrocytic Gliosis after Cortical Lesion in the Marmoset Monkey’, Journal of Neurotrauma, 27(7), pp. 1321–1332.
- Miller, S. A., Dykes, D. D. and Polesky, H. F. (1988) ‘A simple salting out procedure for extracting DNA from human nucleated cells’, Nucleic Acids Research, 16(3), pp. 1215–1215.
- Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) ‘Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology’, Genetics in Medicine, 17(5), pp. 405–424.
- Wiel, L., Baakman, C., Gilissen, D., Veltman, J. A., Vriend, G. and Gilissen, C. (2019) ‘MetaDome: Pathogenicity analysis of genetic variants through aggregation of homologous human protein domains’, Human Mutation, p. humu.23798.
- Paysan-Lafosse, T., Blum, M., Chuguransky, S., Grego, T., Pinto, B. L., Salazar, G. A., Bileschi, M. L., Bork, P., Bridge, A., Colwell, L., et al. (2023) ‘InterPro in 2022’, Nucleic Acids Research, 51(D1), pp. D418–D427.
- Fuller, Z. L., Berg, J. J., Mostafavi, H., Sella, G. and Przeworski, M. (2019) ‘Measuring intolerance to mutation in human genetics’, Nature Genetics, 51(5), pp. 772–776.
- Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2020) ‘The mutational constraint spectrum quantified from variation in 141,456 humans’, Nature, 581(7809), pp. 434–443.
- Nagy, E. and Maquat, L. E. (1998) ‘A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance’, Trends in Biochemical Sciences, 23(6), pp. 198–199.
- Arvanitis, D. N. and Davy, A. (2012) ‘Regulation and misregulation of Eph/ephrin expression’, Cell Adhesion & Migration, 6(2), pp. 131–137.
- Sobreira, N., Schiettecatte, F., Valle, D. and Hamosh, A. (2015) ‘GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same Gene’, Human Mutation, 36(10), pp. 928–930.
- Oliver, K. L., Scheffer, I. E., Bennett, M. F., Grinton, B. E., Bahlo, M. and Berkovic, S. F. (2023) ‘Genes4Epilepsy: An epilepsy gene resource’, Epilepsia, 64(5), pp. 1368–1375.